INVO Fertility (IVF) Non-Current Deferred Tax Liability (2019 - 2023)
INVO Fertility's (IVF) quarterly Non-Current Deferred Tax Liability came in at $1949.0 in Q3 2023, up 71.12% year-on-year from $1139.0 in Q3 2022, and little changed on a QoQ basis from $1949.0 in Q2 2023.
INVO Fertility (IVF) Non-Current Deferred Tax Liability (2019 - 2023) Analysis & Trends
INVO Fertility (IVF) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $1949.0 in Q3 2023.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 71.12% year-over-year to $1949.0 in Q3 2023; TTM through Sep 2023 was $1949.0, a 71.12% increase from a year earlier, with the FY2022 full-year figure at $1949.0, up 71.12% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2023 stood at $1949.0, roughly flat from $1949.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for IVF reached as high as $1949.0 in Q4 2022 and fell as low as $433.0 in Q4 2019.
- Historically, Non-Current Deferred Tax Liability has averaged $997.5 across 5 years, with a median of $804.0 in 2020.
- Across the five-year window, Non-Current Deferred Tax Liability advanced 8.31% in 2020 and jumped 142.86% in 2021, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $433.0 in 2019, then increased by 8.31% to $469.0 in 2020, then jumped by 142.86% to $1139.0 in 2021, then soared by 71.12% to $1949.0 in 2022, then changed by 0.0% to $1949.0 in 2023.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1949.0 in Q3 2023, $1949.0 in Q2 2023, and $1949.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.56 Mn | -3.35 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1,949.00 |
| Sep 30, 2023 | 1,949.00 |
| Jun 30, 2023 | 1,949.00 |
| Jun 30, 2023 | 1,949.00 |
| Mar 31, 2023 | 1,949.00 |
| Mar 31, 2023 | 1,949.00 |
| Dec 31, 2022 | 1,949.00 |
| Dec 31, 2022 | 1,949.00 |
| Sep 30, 2022 | 1,139.00 |
| Sep 30, 2022 | 1,139.00 |
| Jun 30, 2022 | 1,139.00 |
| Jun 30, 2022 | 1,139.00 |
| Mar 31, 2022 | 1,139.00 |
| Mar 31, 2022 | 1,139.00 |
| Dec 31, 2021 | 1,139.00 |
| Dec 31, 2021 | 1,139.00 |
| Sep 30, 2021 | 469.00 |
| Sep 30, 2021 | 469.00 |
| Jun 30, 2021 | 469.00 |
| Jun 30, 2021 | 469.00 |